Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
37.80
-1.64 (-4.16%)
May 12, 2026, 4:08 PM HKT
Market Cap8.26B +75.5%
Revenue (ttm)1.19B +25.1%
Net Income229.49M +14.0%
EPS1.40 +14.2%
Shares Out209.45M
PE Ratio28.23
Forward PEn/a
Dividend0.26 (0.66%)
Ex-Dividend DateJun 3, 2026
Volume205,400
Average Volume225,610
Open39.60
Previous Close39.44
Day's Range37.62 - 39.70
52-Week Range20.10 - 41.40
Beta0.15
RSI53.76
Earnings DateMar 27, 2026

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers digital inflation devices; cardiac valves balloon inflation catheter; guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire; angiography catheter use... [Read more]

Sector Healthcare
Founded 2006
Employees 2,088
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1501
Full Company Profile

Financial Performance

In 2025, HKG:1501's revenue was 1.07 billion, an increase of 25.06% compared to the previous year's 851.95 million. Earnings were 206.23 million, an increase of 13.99%.

Financial numbers in CNY Financial Statements